StockData
YD Bio Ltd logo

YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30
$4.83+0.27 (+5.92%)

Close on Nov 20, 2026Market cap $341.91MP/E –Yield –

YD Bio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$8.04M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.04M–
FY2024Dec 31, 2024-$1.30M–
FY2023Dec 31, 2023-$55.95K–

More YD Bio figures

See a number that looks wrong?